Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin Dose Escalation in Invasive Aspergillosis
NCT00404092Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Oct 2006
- Primary completion
- Oct 2009
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of caspofungin in invasive aspergillosis (IA), sponsored by University of Cologne. Started Oct 2006; status: completed.
02
Drugs
caspofungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00404092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404092.